SEARCH RESULTS for assignee:"sandoz gmbh"

Showing 1 to 20 of 22 results

Share this

Reel/Frame

Last Update:

Patent(s)

(X0) 15756214: Process for Preparing Ceftolozane from 7-Aminocephalosporanic Acid (7-ACA)

(A1) 20180338981: Process for Preparing Ceftolozane from 7-Aminocephalosporanic Acid (7-ACA)

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15738016: Process for the Preparation of Carbamoylamino Pyrazole Derivatives

(A1) 20180305319: Process for the Preparation of Carbamoylamino Pyrazole Derivatives

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15737900: Synthesis of Phosphoramidates

(A1) 20180298045: Synthesis of Phosphoramidates

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15522889: Active Acrylamides

(A1) 20180282336: Active Acrylamides

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15763649: Solid Pharmaceutical Composition Comprising Amorphous Sofosbuvir

(A1) 20180271890: Solid Pharmaceutical Composition Comprising Amorphous Sofosbuvir

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15751316: Asymmetric Bisamidation of Malonic Ester Derivatives

(A1) 20180237378: Asymmetric Bisamidation of Malonic Ester Derivatives

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15751316: Asymmetric Bisamidation of Malonic Ester Derivatives

(A1) 20180237378: Asymmetric Bisamidation of Malonic Ester Derivatives

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15560527: Crystalline Forms of Cabozantinib Phosphate And Cabozantinib Hydrochloride

(A1) 20180111903: Crystalline Forms of Cabozantinib Phosphate And Cabozantinib Hydrochloride

(B2) 1: Crystalline Forms of Cabozantinib Phosphate And Cabozantinib Hydrochloride

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15500627: Synthesis of Phosphoramidates

(A1) 20170218006: Synthesis of Phosphoramidates

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15750849: Form C of Avibactam Sodium

(A1) 20180193351: Form C of Avibactam Sodium

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15500627: Synthesis of Phosphoramidates

(A1) 20170218006: Synthesis of Phosphoramidates

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15575771: Synthesis of Phosphoramidates

(A1) 20180162896: Synthesis of Phosphoramidates

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15575771: Synthesis of Phosphoramidates

(A1) 20180162896: Synthesis of Phosphoramidates

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15549720: Method For Producing A Recombinant Protein Of Interest

(A1) 20180023067: Method For Producing A Recombinant Protein Of Interest

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15501295: Novel Route of Synthesis for the Preparation of Suvorexant

(A1) 20170217947: Novel Route of Synthesis for the Preparation of Suvorexant

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15500627: Synthesis of Phosphoramidates

(A1) 20170218006: Synthesis of Phosphoramidates

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15538266: SELECTIVE REDUCTION OF CYSTEINE RESIDUES IN IL-17 ANTIBODIES

(A1) 20170369567: SELECTIVE REDUCTION OF CYSTEINE RESIDUES IN IL-17 ANTIBODIES

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15554552: Constitutive Yeast LLP Promotor-Based Expression Systems

(A1) 20180079788: Constitutive Yeast LLP Promotor-Based Expression Systems

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15501295: Novel Route of Synthesis for the Preparation of Suvorexant

(A1) 20170217947: Novel Route of Synthesis for the Preparation of Suvorexant

Assignee(s)

Reel/Frame

Last Update:

Patent(s)

(X0) 15560519: Cabozantinib Salts And Their Use As Anti-Cancer Agents

(A1) 20180110769: Cabozantinib Salts And Their Use As Anti-Cancer Agents

Assignee(s)